Insider: Mottiwala Aziz Chief Commercial Officer - Tarsus Pharmaceuticals, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 47,557 | 0 | 47,557 |
| Value | $2,676,983.53 | $0.00 | $2,676,983.53 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 06/09/2025 | DDS | 17,500 | Direct | COM | $43.76 | $765,800.00 | 47,557 |
| 03/20/2025 | DDS | 3,365 | Direct | COM | $50.11 | $168,620.15 | 65,057 |
| 03/19/2025 | DDS | 3,557 | Direct | COM | $47.40 | $168,601.80 | 68,422 |
| 03/18/2025 | DDS | 3,643 | Direct | COM | $46.29 | $168,634.47 | 71,979 |
| 03/18/2024 | DDS | 4,766 | Direct | COM | $30.60 | $145,839.60 | 54,075 |
| 07/19/2023 | DDS | 2,400 | Direct | COM | $20.05 | $48,120.00 | 45,806 |
| 06/08/2023 | DDS | 100 | Direct | COM | $20.00 | $2,000.00 | 48,086 |
| 06/07/2023 | DDS | 2,500 | Direct | COM | $19.34 | $48,350.00 | 48,186 |
| 06/06/2023 | DDS | 2,143 | Direct | COM | $18.61 | $39,881.23 | 50,686 |
| 03/20/2023 | DDS | 358 | Direct | COM | $12.61 | $4,514.38 | 53,907 |
| 03/17/2023 | DDS | 339 | Direct | COM | $13.28 | $4,501.92 | 54,265 |
| 03/16/2023 | DDS | 336 | Direct | COM | $13.43 | $4,512.48 | 54,604 |
| 11/15/2022 | DDS | 6,857 | Direct | COM | $17.72 | $121,506.04 | 49,729 |
| 11/08/2021 | DDS | 1,889 | Direct | COM | $28.11 | $53,099.79 | 50,203 |
| 11/05/2021 | DDS | 11 | Direct | COM | $28.11 | $309.21 | 52,092 |
| 11/04/2021 | DDS | 100 | Direct | COM | $28.03 | $2,803.00 | 52,103 |
| 11/02/2021 | DDS | 5,458 | Direct | COM | $26.75 | $146,017.87 | 52,745 |
| 11/02/2021 | DDS | 542 | Direct | COM | $27.07 | $14,672.48 | 52,203 |
| 09/10/2021 | DDS | 2,593 | Direct | COM | $22.15 | $57,434.95 | 58,203 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research